PRESS RELEASE
Q1 2022/2023 REVENUES: €20.9M
New SaaS contracts Q1 2022/2023: €1.2m
Growth in SaaS revenues: 11%
Q1 revenues: €20.9 million
Quarter ended | Change | ||
Unaudited (K€) | 2022 | 2021 | |
SaaS | 9 093 | 8 186 | 11% |
Maintenance | 4 637 | 4 646 | 0% |
Licenses | 630 | 1 177 | -46% |
Software revenues | 14 360 | 14 009 | 2,5% |
Consulting Services | 6 568 | 7 234 | -9% |
Revenues | 20 928 | 21 243 | -1,5% |
Revenues for the quarter amounted to €20.9 million, down 1.5% compared with the first quarter of the previous year.
Thanks to the good signing dynamics of the previous year, SaaS activity grew by 11% during the quarter. This strong growth was recorded in almost all the countries where
The slowdown in the Licenses activity observed in the second half of the previous fiscal year continued in
Q1 new SaaS contracts: €1.2 M
Quarter ended | Change | ||
Unaudited (K€) | 2022 | 2021 | |
New SaaS contract signing (ACV*) | 1 215 | 1 664 | -27,0% |
* New signatures expressed in ACV (Annual Contract Value) highlighting the average annual additional revenue that will be generated after deployment of the contracts concerned.
The volume of SaaS signatures for the first quarter of the year was €1.2 million.
As a reminder, the previous year had recorded a record level of signatures for a 1st quarter with a significant restart of activity after the health crisis.
Among these new signatures:
- in
France , a signature with a distribution group wishing to accelerate its digital transformation by equipping itself withGenerix Group's EDI and Invoice Services solutions in SaaS mode. This contract completes a first SaaS migration withGenerix Group's TMS solution in 2021. - in
Spain , the adoption of the Generix WMS solution andData Power for data analysis by a company specialized in the food industry.
Forecast
As indicated at the time of the presentation of the 2021/2022 results, the current financial year is subject to contrasting factors:
- activity in
Russia , currently stable but subject to changes in the international context - inflation and its impact on the increase in the wage bill
- the expected recovery in
North America after the low point in the second half of 2021-2022 - the dynamic of SaaS signatures in the wake of the 2021/2022 rebound, and
- continued R&D investment to support the competitiveness and performance of the Group's solutions.
On this basis,
Supplemental and non-IFRS Financial Information
Supplemental non-IFRS information (above-mentioned as EBITDA) presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Company’s supplemental non-IFRS financial information may not be comparable to similarly titled non-IFRS measures used by other companies.
Next financial press release:
Publication of second quarter sales for fiscal year 2022/2023
About
Its collaborative platform, Generix Supply
Generix Supply
Founded in
Attachment
- EXT-EN-FINA-CP-CA-Q1-2022-2023
© OMX, source